124 related articles for article (PubMed ID: 38299401)
1. Curcumin Inhibits Vasculogenic Mimicry Via Regulating ETS-1 in Renal Cell Carcinoma.
Chong Y; Xu S; Liu T; Guo P; Wang X; He D; Zhu G
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38299401
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
[TBL] [Abstract][Full Text] [Related]
3. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
Fan X; Huang J; Hu B; Zhou J; Chen L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
[TBL] [Abstract][Full Text] [Related]
4. CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway.
Cheng R; Wang B; Cai XR; Chen ZS; Du Q; Zhou LY; Ye JM; Chen YL
Onco Targets Ther; 2020; 13():11485-11498. PubMed ID: 33204103
[TBL] [Abstract][Full Text] [Related]
5. Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma.
Ding J; Cui XG; Chen HJ; Sun Y; Yu WW; Luo J; Xiao GQ; Chang C; Qi J; Yeh S
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406411
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.
Qin Y; Zhao W; Cheng L; Wu S; Wu Q; Gao J; Bian Z; Ma L
Int J Clin Exp Pathol; 2019; 12(7):2462-2473. PubMed ID: 31934073
[TBL] [Abstract][Full Text] [Related]
10. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
11. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
Han H; Du L; Cao Z; Zhang B; Zhou Q
Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2.
Zhao N; Sun BC; Sun T; Ma YM; Zhao XL; Liu ZY; Dong XY; Che N; Mo J; Gu Q
Med Oncol; 2012 Dec; 29(5):3599-607. PubMed ID: 22562824
[TBL] [Abstract][Full Text] [Related]
14. Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells.
Cong R; Sun Q; Yang L; Gu H; Zeng Y; Wang B
J Exp Clin Cancer Res; 2009 Sep; 28(1):124. PubMed ID: 19735546
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.
Chiablaem K; Lirdprapamongkol K; Keeratichamroen S; Surarit R; Svasti J
Anticancer Res; 2014 Apr; 34(4):1857-64. PubMed ID: 24692720
[TBL] [Abstract][Full Text] [Related]
16. The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma.
Irani S; Dehghan A
J Int Soc Prev Community Dent; 2018; 8(2):110-117. PubMed ID: 29780735
[TBL] [Abstract][Full Text] [Related]
17. Mig-7 expression and vasculogenic mimicry in malignant ovarian tumors.
Czekierdowski A; Czekierdowska S; Stachowicz N; Łoziński T; Gurynowicz G
Ginekol Pol; 2017; 88(10):552-561. PubMed ID: 29192416
[TBL] [Abstract][Full Text] [Related]
18. SOX7 blocks vasculogenic mimicry in oral squamous cell carcinoma.
Hong KO; Oh KY; Yoon HJ; Swarup N; Jung M; Shin JA; Kim JH; Chawla K; Lee JI; Cho SD; Hong SD
J Oral Pathol Med; 2021 Sep; 50(8):766-775. PubMed ID: 33733517
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
Yeo C; Han DS; Lee HJ; Lee EO
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
[TBL] [Abstract][Full Text] [Related]
20. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.
Hsu JL; Leu WJ; Hsu LC; Hsieh CH; Guh JH
Oncol Lett; 2024 Apr; 27(4):170. PubMed ID: 38455663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
